Key result
Acute eosinophilic myocarditis is linked to a ~24% 3-year rate of death or HTx.
Cohort (n=156)
Yes
Acute eosinophilic myocarditis carries a high mortality and frequently presents without peripheral eosinophilia, emphasizing the critical role of endomyocardial biopsy for diagnosis.
Answers are grounded in this paper and cite their sources.
Acute EM carries 15-24% short-term mortality despite immunosuppression; extends case-series data on presentation and predictors but leaves optimal management open.
Background Acute eosinophilic myocarditis (EM) is considered a highly lethal clinical condition, yet current knowledge relies largely on small case series. Robust data on its clinical presentation, associated conditions, management, and outcomes are lacking. Methods We conducted an international, multicenter, retrospective cohort study across 53 centers on five continents. Among 193 patients with histologically confirmed acute EM identified between 1992 and 2023, 156 met inclusion criteria after excluding cases with insufficient data, symptom duration ›30 days, or unconfirmed pathology. Results Median age was 48 years (IQR 34–59), with a predominance of males (67%). Only two patients were ≤16 years. Dyspnea (76%), fever (61%), and chest pain (53%) were the most frequent presenting symptoms. Peripheral eosinophilia was only reported in 57%. Median left ventricular ejection fraction (LVEF) at presentation was 32% (IQR 25–48%). EM was associated with eosinophilic granulomatosis with polyangiitis (22%), hypersensitivity reactions (14%), idiopathic/undefined etiologies (45%), and miscellaneous causes (19%). In–hospital death or heart transplantation (HTx) occurred in 23 patients (15%), while 44% being treated with temporary mechanical circulatory support and 92% with immunosuppressive agents. One– and three–year cumulative rates of death or HTx were 19% and 24%, respectively. A higher—but not statistically significant—3-year event rate was observed in hypersensitivity–related EM compared with EGPA–associated EM (46% vs. 13%; p=0.15). Increased age, decreased LVEF on admission and no immunosuppressive therapy during hospitalization were independent predictors of death or HTx. Conclusions Acute EM frequently presents without peripheral eosinophilia, underscoring the essential role of endomyocardial biopsy for diagnosis. Despite contemporary management, in–hospital and mid–term mortality remain high. Effective patient–specific strategies to improve outcomes in this rare but life–threatening condition are needed.
No takes yet. Share an insight, caveat, or question.
Palazzini et al. (2026) conducted a cohort in Acute eosinophilic myocarditis (n=156). Acute eosinophilic myocarditis was evaluated on Death or heart transplantation (HTx) at 3 years. Acute eosinophilic myocarditis was associated with high mortality, with in-hospital death or heart transplantation occurring in 15% of patients and a 3-year cumulative rate of 24%.
Synapse has enriched 10 related papers. Consider them for comparative context: